Compare ZVRA & SMWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | SMWB |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 502.7M | 497.8M |
| IPO Year | 2015 | 2021 |
| Metric | ZVRA | SMWB |
|---|---|---|
| Price | $8.92 | $5.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $21.71 | $13.57 |
| AVG Volume (30 Days) | ★ 1.0M | 325.1K |
| Earning Date | 03-10-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | $84,388,000.00 | ★ $275,429,000.00 |
| Revenue This Year | $333.64 | $16.87 |
| Revenue Next Year | $43.58 | $13.51 |
| P/E Ratio | $16.79 | ★ N/A |
| Revenue Growth | ★ 244.60 | 14.25 |
| 52 Week Low | $6.19 | $5.48 |
| 52 Week High | $13.16 | $17.64 |
| Indicator | ZVRA | SMWB |
|---|---|---|
| Relative Strength Index (RSI) | 54.06 | 25.79 |
| Support Level | $8.75 | $5.48 |
| Resistance Level | $9.60 | $6.00 |
| Average True Range (ATR) | 0.46 | 0.32 |
| MACD | 0.04 | -0.09 |
| Stochastic Oscillator | 58.55 | 5.14 |
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.